AU Stock MarketDetailed Quotes
OSLOB OncoSil Medical Ltd
- 0.005
- +0.001+25.00%
20min DelayMarket Closed Jul 19 16:00 AET
16.99MMarket Cap0.00P/E (Static)
0.005High0.004Low7.54MVolume0.004Open0.004Pre Close33.27KTurnover0.00552wk High0.26%Turnover Ratio3.40BShares0.00252wk Low--EPS TTM14.26MFloat Cap0.005Historical High0.00P/E (Static)2.85BShs Float0.002Historical Low--EPS LYR25.00%Amplitude--Dividend TTM0.00P/B1Lot Size--Div YieldTTM
OncoSil Medical Ltd Key Stats
Quarterly+Annual
YOY
| (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | |
|---|---|---|---|---|
| Total revenue | 58.63%367.68K | 8.79%231.79K | 213.07K | |
| Operating revenue | 58.63%367.68K | 8.79%231.79K | --213.07K | ---- |
| Cost of revenue | 63.37%1.59M | 1.19%972.47K | 961.02K | |
| Gross profit | -64.86%-1.22M | 0.97%-740.69K | -747.95K | |
| Operating expense | 6.60%11.51M | -2.43%10.8M | 50.35%11.06M | 7.36M |
| Selling and administrative expenses | -6.71%6.69M | 7.80%7.17M | 291.08%6.65M | --1.7M |
| -Selling and marketing expense | -64.77%130.42K | -45.94%370.21K | --684.77K | ---- |
| -General and administrative expense | -3.55%6.56M | 13.96%6.8M | 250.82%5.97M | --1.7M |
| Research and development costs | 19.97%2.85M | -17.70%2.38M | -22.50%2.89M | --3.73M |
| Depreciation amortization depletion | 38.60%175.89K | -31.32%126.91K | 23.77%184.78K | --149.29K |
| -Depreciation and amortization | 38.60%175.89K | -31.32%126.91K | 23.77%184.78K | --149.29K |
| Other operating expenses | 59.77%1.79M | -16.26%1.12M | -24.83%1.34M | --1.78M |
| Operating profit | -10.34%-12.73M | 2.33%-11.54M | -60.51%-11.81M | -7.36M |
| Net non-operating interest income (expenses) | 644.69%51.71K | -114.22%-9.49K | -28.85%66.74K | 93.8K |
| Non-operating interest income | 517.97%62.61K | -87.72%10.13K | -21.36%82.48K | --104.88K |
| Non-operating interest expense | --5 | ---- | 25.55%1.08K | --861 |
| Total other finance cost | -44.48%10.9K | 33.81%19.62K | 43.45%14.67K | --10.22K |
| Other net income (expenses) | 67.44%1.16M | -38.58%692.11K | -60.51%1.13M | 2.85M |
| Other non-operating income (expenses) | 67.44%1.16M | -38.58%692.11K | -60.51%1.13M | --2.85M |
| Income before tax | -5.74%-11.34M | -2.81%-10.73M | -144.81%-10.43M | -4.26M |
| Income tax | 0 | 0 | 0 | 0 |
| Earnings from equity interest net of tax | ||||
| Net income | -5.74%-11.34M | -2.81%-10.73M | -144.81%-10.43M | -4.26M |
| Net income continuous operations | -5.74%-11.34M | -2.81%-10.73M | -144.81%-10.43M | ---4.26M |
| Noncontrolling interests | ||||
| Net income attributable to the company | -5.74%-11.34M | -2.81%-10.73M | -144.81%-10.43M | -4.26M |
| Preferred stock dividends | ||||
| Other under preferred stock dividend | ||||
| Net income attributable to common stockholders | -5.74%-11.34M | -2.81%-10.73M | -144.81%-10.43M | -4.26M |
| Diluted earnings per share | ||||
| Basic earnings per share | ||||
| Dividend per share | ||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
%Chg